| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
AFP
|
alpha-fetoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CA9
|
carbonic anhydrase IX
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FAS
|
Fas cell surface death receptor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC9
|
histone deacetylase 9
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR193B
|
microRNA 193b
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RRM1
|
ribonucleotide reductase M1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THBS1
|
thrombospondin 1
|
|
TP53
|
tumor protein p53
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
ZAK
|
sterile alpha motif and leucine zipper containing kinase AZK
|
